Eslami Ahmad Ali, Shariatinia Sedigheh, Khoshgoftar Mohadeseh
Department of Health Education and Promotion, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Student Research Committee, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Addict Health. 2021 Oct;13(4):268-276. doi: 10.22122/ahj.v13i4.1195.
Psychotropic drugs can cause many complications and side effects including cognitive, behavioral, and psychological disorders. In recent years, the Iranian youth and adolescents have growingly been using psychotropic drugs. Therefore, this study analyzes the overall prevalence of psychotropic drugs and the relevant factors among the Iranian youth through a systematic review and a meta-analysis.
Based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist, this study includes a systematic review and a meta-analysis. For bias prevention, qualitative evaluation and data extraction were performed independently by two people. Different databases (PubMed, Science Direct, Springer, Wiley, ISI Web of Science, Cochran, Google Scholar, Magiran, IranMedex, SID, ISC) were investigated online, and data analysis was done in Stata software.
In total, 5 articles were selected for the meta-analysis phase. They had been published between 2008 and 2018. According to the meta-analysis results, the overall prevalence of psychotropic drugs was 4.18% [95% confidence interval (CI): 2.52-5.84] in the Iranian youth population. The overall prevalence of psychotropic drugs was 4.74% (95% CI: 1.49-7.99) and 1.06% (95% CI: 0.72-1.41) in young men and women, respectively. Three studies indicated a significant relationship between gender and the use of psychotropic drugs. In other words, the prevalence of psychotropic drugs was significantly higher in boys than in girls (P < 0.05).
The research results showed that family, parents, close friends, and unemployment were the factors affecting the prevalence of psychotropic drugs in the youth and adolescents.
精神药物可引发诸多并发症和副作用,包括认知、行为及心理障碍。近年来,伊朗青年和青少年使用精神药物的情况日益增多。因此,本研究通过系统评价和荟萃分析,剖析伊朗青年中精神药物的总体流行率及相关因素。
基于系统评价和荟萃分析的首选报告项目(PRISMA)清单,本研究涵盖系统评价和荟萃分析。为防止偏倚,由两人独立进行定性评估和数据提取。在线检索不同数据库(PubMed、Science Direct、Springer、Wiley、ISI Web of Science、Cochran、Google Scholar、Magiran、IranMedex、SID、ISC),并使用Stata软件进行数据分析。
总共选取了5篇文章用于荟萃分析阶段。这些文章发表于2008年至2018年之间。根据荟萃分析结果,伊朗青年人群中精神药物的总体流行率为4.18%[95%置信区间(CI):2.52 - 5.84]。青年男性和女性中精神药物的总体流行率分别为4.74%(95%CI:1.49 - 7.99)和1.06%(95%CI:0.72 - 1.41)。三项研究表明性别与精神药物使用之间存在显著关系。换言之,男孩中精神药物的流行率显著高于女孩(P < 0.05)。
研究结果显示,家庭、父母、密友和失业是影响青年和青少年中精神药物流行率的因素。